Brad Sullivan, publisher of Behind the Markets, would like our readers to discover another tiny biotech stock that could provide huge gains. To learn more read below.
 | You're receiving this email because you are subscribed to Trading Tips,
if you no longer wish to receive these emails you can Manage Subscriptions. |  |  | |
| EDITOR'S NOTE: Brad Sullivan, publisher of Behind the Markets, would like our readers to discover another tiny biotech stock that could provide huge gains. To learn more read below. | | | Dear Investor,
On October 1st of 2018, super-investor Dylan Jovine recommended shares of Tesaro... 63 days later it was taken over for an easy 91% profit.
On October 19th of 2018 he recommended Pacific Biosciences... 4 days later it was taken over for a quick 72% gain...
On January 4th, 2019 he recommended Loxo Oncology... 3 days later it was taken over for a super-fast 71% gain...
And last month he took easy 148% profits on Array Biopharma after Pfizer agreed to acquire it.
Discover Mr. Jovine's Next Winner Here >>>
This guy is an absolute genius. The question now is, what's Mr. Jovine's next move?
He just recommended another tiny biotech stock that just won a patent on a new kind of genetic software that can "Cut & Paste" any disease from your body.
The age-old investor's wisdom to "follow the smart money" has never been more appropriate. You now have the opportunity - on any level you choose - to put your money right next to money that "always wins."
The Best Stock Recommendation You'll Hear All Year
My name is Brad Sullivan, and I'm the Publisher at Behind the Markets.
By the time Dylan became disgusted with Wall Street and sold his brokerage firm at age 30, he'd made millions. I don't bring this up to brag -- but to drive home the point I'm about to make:
If I woke up tomorrow morning and found that I literally had only one measly dollar left to my name ... I would be 100% confident that I could make back my millions in relatively short order.
And how would I start? I'd hitch my wagon to Dylan Jovine and invest that dollar in the stock that he's drooling over right now.
I'm convinced that this will be the best stock idea you've heard all year. This is a recommendation that can get taken over any day - and make you 300% richer in the next 6 months.
If you're patient, however, I'm confident that you can easily turn every $1,000 you invest into $1.57 million.
You'll discover why...
| • The Nobel Prize Committee is calling it "The Holy Grail of Medicine" | | | | • The Wall Street Journal reports the company is "transforming medicine." | | | | • 60 Minutes reports the company is "revolutionizing the search for new drugs." | | | Never before has so much money invested in a new treatment so quickly.
And because of that, it's going to create more millionaires than any other single breakthrough in history. More than the internet, more than computers, more than cars.
Investor's Business Daily estimates the market is worth at least $75 billion market.
But right now, its stock price is just a tiny fraction of that size.
That's if the company doesn't get taken over for fast 300% gains first.
CLICK HERE to see how you can profit from this rare opportunity>>>
Sincerely,
Brad Sullivan
Publisher,
Behind the Markets
| | |
| | |
| From time to time your free Trading Tips newsletter subscription is supplemented by paid sponsorships, like the one above. Please read all disclaimers. Rest assured that your information was not shared with this sponsor. Please note that Trading Tips has not independently reviewed the validity of the claims or statements contained within this sponsorship, and we are not responsible for any errors or omissions.
Never invest in a security or idea featured on our site or in our emails unless you can afford to lose your entire investment. We are not registered investment advisors or brokers/dealers and we do not purport to be. We make no representations, warranties or guarantees as to the accuracy or completeness of the content featured on our site or in our emails. Furthermore, the article authors and contributors featured on this site may own securities mentioned in their articles and not disclose this information. Trading Tips does not endorse any investing or trading products or newsletters advertised in this email or on our web site. Please be sure to read our
Go here to get more information from http://www.TradingTips.com | | | | | |
No comments:
Post a Comment